The shift from cellular dormancy to cell proliferation was also evident through bone TME remodeling by interleukin-6 (IL-6) and the tumor necrosis factor-alpha (TNFα) in metastatic breast cancer cells [42]. The gene discussed is IL6; the disease is breast carcinoma.